Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids

NCT01441635 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

271

Enrollment

INDUSTRY

Sponsor class

Conditions

Heavy Uterine Bleeding
Uterine Fibroids

Interventions

DRUG: Elagolix
DRUG: Placebo
DRUG: Estradiol/Norethindrone acetate (E2/NETA)
DRUG: Estradiol
DRUG: Progesterone

Sponsor

AbbVie (prior sponsor, Abbott)